The Molecular Biology of Myeloma

David S. Siegel, MD, PhD
Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
July 29, 2015

The Cost of Cancer Care from a Patient Perspective

Dr. S. Yosuf Zafar has found that out of pocket costs impact patient well-being, quality of life, and quality of care. He stresses that costs need to be reduced in order to provide the best medical treatment for all patients.

January 13, 2015

When to Use Breast Cancer Index

Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the circumstances in which they would use the Breast Cancer IndexSM (BCI) to assist in determining whether to extend the adjuvant therapy of women with breast cancer beyond 5 years.